Titan Biotech

Titan Biotech P/CF

Delisted·Sep 16, 2026

The P/CF (Price-to-Cash-Flow Ratio) of Titan Biotech (524717.BO) as of Oct 18, 2026 is 50.13. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 75.79 — a change of -33.85% (lower).

P/CF

50.13

YoY

-33.85%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Titan Biotech is 2026 50.13 . P/CF (Price-to-Cash-Flow Ratio) of Titan Biotech was 2025 75.79 . It decreases by -33.85% lower compared to the previous year.

The Titan Biotech P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
278.98 INR
Jan 1, 2020
249.35 INR
Jan 1, 2021
79.92 INR
Jan 1, 2022
69.20 INR
Jan 1, 2023
72.01 INR
Jan 1, 2024
72.12 INR
Jan 1, 2025
75.79 INR
Jan 1, 2026
50.13 INR
The Titan Biotech P/CF history
YEARP/CFYoY
50.13-33.85%
75.79+5.08%
72.12+0.15%
72.01+4.07%
69.20-13.42%
79.92-67.95%
249.35-10.62%
278.98-65.32%
804.50-93.00%
11,493.44+3,513.38%
318.08-137.54%
-847.22-75.49%
-3,456.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Titan Biotech Stock analysis

What does Titan Biotech do? Titan Biotech Ltd is a holding company headquartered in Delhi, India, listed on the stock exchange on 2 January 1995. With a workforce of 396 employees, the firm operates within the Materials sector, specifically in the Chemicals industry. It functions as a manufacturer and exporter of biological products for various industries, including pharmaceuticals, nutraceuticals, food and beverages, biotechnology, cosmetics, veterinary care, animal feed, and agriculture. The company produces peptones, biological extracts, culture media, and chemicals. Its product portfolio spans food ingredients like hydrolyzed vegetable protein and yeast extract, as well as collagen and proteins such as soya protein isolate and collagen peptides. Titan Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Titan Biotech stock

P/CF (Price-to-Cash-Flow Ratio) of Titan Biotech is 50.13 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Titan Biotech changed from 75.79 to 50.13, representing a -33.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Titan Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Titan Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Titan Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Titan Biotech